Indian markets are likely edge higher in Thursday's trading session on firm global cues. SGX Nifty, up 2.15%, also suggests a positive opening for Indian equities.
Asian shares gained in early deals, tracking Wall Street's rally after positive trial results of an experimental covid-19 treatment, a US Federal Reserve pledge to shore up the economy and a jump in oil prices.
A top US health official said Gilead Sciences Inc's antiviral drug remdesivir is likely to become the standard of care for covid-19 after early results from a clinical trial showed it helped certain patients recover more quickly.
Investors expect the ensuing virus treatments to be critical in helping countries emerge from self-imposed lockdowns aimed at curbing the